What is the official website of BOTOX® Cosmetic (onabotulinumtoxinA) ?

The official website of BOTOX® Cosmetic (onabotulinumtoxinA) is https://hcp.botoxcosmetic.com/.

What is BOTOX® Cosmetic (onabotulinumtoxinA)'s cybersecurity risk score?

BOTOX® Cosmetic (onabotulinumtoxinA) has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has BOTOX® Cosmetic (onabotulinumtoxinA) experienced?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has BOTOX® Cosmetic (onabotulinumtoxinA) been affected by any supply chain cyber incidents ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have SOC 2 Type 1 certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not certified under SOC 2 Type 1.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have SOC 2 Type 2 certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) does not hold a SOC 2 Type 2 certification.

Does BOTOX® Cosmetic (onabotulinumtoxinA) comply with GDPR ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not listed as GDPR compliant.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have PCI DSS certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) does not currently maintain PCI DSS compliance.

Does BOTOX® Cosmetic (onabotulinumtoxinA) comply with HIPAA ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not compliant with HIPAA regulations.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have ISO 27001 certification ?

According to Rankiteo,BOTOX® Cosmetic (onabotulinumtoxinA) is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does BOTOX® Cosmetic (onabotulinumtoxinA) operate in ?

BOTOX® Cosmetic (onabotulinumtoxinA) operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA) employs approximately 0 people worldwide.

Does BOTOX® Cosmetic (onabotulinumtoxinA) own any subsidiaries ?

BOTOX® Cosmetic (onabotulinumtoxinA) presently has no subsidiaries across any sectors.

How many LinkedIn followers does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA)'s official LinkedIn profile has approximately 2,415 followers.

What is the NAICS classification code for BOTOX® Cosmetic (onabotulinumtoxinA) ?

BOTOX® Cosmetic (onabotulinumtoxinA) is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have a Crunchbase profile ?

No, BOTOX® Cosmetic (onabotulinumtoxinA) does not have a profile on Crunchbase.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have a LinkedIn profile ?

Yes, BOTOX® Cosmetic (onabotulinumtoxinA) maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/botox-cosmetic-usa.

How many cybersecurity incidents has BOTOX® Cosmetic (onabotulinumtoxinA) experienced ?

As of September 22, 2026, Rankiteo reports that BOTOX® Cosmetic (onabotulinumtoxinA) has experienced 2 cybersecurity incidents.

How many peer or competitor companies does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA) has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has BOTOX® Cosmetic (onabotulinumtoxinA) faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Vulnerability.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

BOTOX® Cosmetic (onabotulinumtoxinA) Vendor Cyber Rating & Cyber Score

botoxcosmetic.com

Add Your Compliance Badge

Please see Prescribing Information and Important Safety Information, including Boxed Warning, below. A leader in aesthetic neurotoxins for decades, BOTOX® Cosmetic is the only neurotoxin that’s FDA approved for simultaneous treatment in adults for 3 areas of the face: to temporarily improve the appearance of moderate to severe forehead line, lateral canthal lines, and glabellar lines.1-5 Follow our page to learn how BOTOX® Cosmetic can support you and your patients. REFERENCES: 1. BOTOX® Cosmetic Prescribing Information, July 2020. 2. Dysport® Prescribing Information, January 2023. 3. Xeomin® Prescribing Information, August 2021. 4. Jeuveau® Prescribing Information, January 2020. 5. Daaxify™ Prescribing Information, September 2022.

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

AbbVie

Vulnerability

100

4/2026

EGAABB177565877...

BOTOX® Cosmetic (on...

Breach

100

6/2023

ABB0473723

Loading…

A.I.

BC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incident Types BC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incident History - BC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

BOTOX® Cosmetic (onabotulinumtoxinA) Subsidiaries

BC

Pharmaceutical Manufacturing

Website: https://hcp.botoxcosmetic.com/

Company Size: 0

AbbViePharmaceutical Manufacturing

AbbVie | ImmunologyPharmaceutical Manufacturing

AbbVie | OncologyPharmaceutical Manufacturing

AbbVie | UKPharmaceutical Manufacturing

AbbVie | NeurosciencePharmaceutical Manufacturing

AbbVie | FrancePharmaceutical Manufacturing

Eye CarePharmaceutical Manufacturing

Pharmacyclics, an AbbVie CompanyPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

AbbVie | VirologyPharmaceutical Manufacturing

AbbVie | EspañaPharmaceutical Manufacturing

AbbVie | AustraliaPharmaceutical Manufacturing

AbbVie Contract ManufacturingPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

Natrelle Breast ImplantsPharmaceutical Manufacturing

Allergan Aesthetics Plastic and Regenerative Medicine PortfolioMedical Equipment Manufacturing

Allergan Medical InstitutePharmaceutical Manufacturing

Allergan Aesthetics, an AbbVie CompanyPharmaceutical Manufacturing

Loading…

BOTOX® Cosmetic (onabotulinumtoxinA) Similar Companies

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Loading…

NEWS

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 09, 2025 07:00 AM

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of "The One & Only"...

Read Article

June 24, 2024 07:00 AM

How to spot fake Botox, or 'Faux-Tox,' and other skincare dupes and beauty counterfeit knockoffs

Fake Botox, skincare dupes and counterfeit cosmetics are not only impacting wallets, but can also pose major health concerns.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-94426

SUMMARY

A vulnerability was determined in xuxueli xxl-job up to 3.5.0. The impacted element is an unknown function of the file /jobgroup/insert. This manipulation of the argument Name causes cross site scripting. The attack can be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 3.5)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.1

REFERENCES

CVE-2026-94425

SUMMARY

A vulnerability was found in Moore Threads MTT S80 Driver Package 340.150. The affected element is the function sub_140006F0C in the library mtdispkm64.sys of the component IOCTL Handler. The manipulation results in improper privilege management. Attacking locally is a requirement. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 8.8)

cvss2

Base Score: 6.8

Complexity: LOW

AV:L/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-94627

SUMMARY

vLLM Mooncake connector through 0.29.0 fails to properly manage GPU KV cache block ownership when concurrent child requests share a single transfer ID in prefill/decode disaggregated deployments. Attackers can trigger GPU memory exhaustion by submitting completion requests with multiple prompts, causing orphaned KV cache blocks to accumulate until process restart and eventually preventing legitimate requests from executing.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-94626

SUMMARY

vLLM through 0.29.0 fails to validate the tp_size parameter in kv_transfer_params on OpenAI-compatible completion endpoints, allowing attackers to allocate unbounded memory. Attackers can supply arbitrary tp_size values in prefill/decode disaggregated deployments to exhaust memory and trigger kernel OOM-kill of the decode worker process.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-94625

SUMMARY

vLLM through 0.29.0 contains a resource exhaustion vulnerability in MooncakeConnector where rejected prefill requests create ownerless transfer placeholders that are never reclaimed. Attackers can send rejected requests to exhaust sender task pools, causing valid requests to be delayed by up to 480 seconds while health checks continue returning success.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

BOTOX® Cosmetic (onabotulinumtoxinA) Vendor Cyber Rating & Cyber Score

BC A.I CyberSecurity Scoring

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News & History

BC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BC vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BC (X = Date, Y = Severity)

BOTOX® Cosmetic (onabotulinumtoxinA) Subsidiaries

BC

BOTOX® Cosmetic (onabotulinumtoxinA) Similar Companies

AbbVie

Astellas Pharma

Eli Lilly and Company

MACLEODS PHARMACEUTICALS LTD.

Grifols

Viatris

Bristol Myers Squibb

Hikma Pharmaceuticals

Catalent

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

How to spot fake Botox, or 'Faux-Tox,' and other skincare dupes and beauty counterfeit knockoffs

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News & History

BC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BC vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BC (X = Date, Y = Severity)

BOTOX® Cosmetic (onabotulinumtoxinA) Subsidiaries

BC

BOTOX® Cosmetic (onabotulinumtoxinA) Similar Companies

AbbVie

Astellas Pharma

Eli Lilly and Company

MACLEODS PHARMACEUTICALS LTD.

Grifols

Viatris

Bristol Myers Squibb

Hikma Pharmaceuticals

Catalent

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

How to spot fake Botox, or 'Faux-Tox,' and other skincare dupes and beauty counterfeit knockoffs

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo